Mesial Temporal

Skip to main content
NeuroPace, Inc.
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz
  • Product
    • The RNS System
    • nSight Platform
    • MRI Safety
    • DIXI US Products
  • Clinical Benefits
    • Seizure Reduction
    • Quality of Life
    • Proven Safety
  • Actionable Insights
    • Real World EEG Data
    • Monitor Patients Remotely
    • Assess Treatment Effects
    • Counsel Patients
  • Patient Selection
    • Neocortical
    • Mesial Temporal
  • Education
    • Webinars
    • RNS System Education
    • Fellows Education
    • Programming Resources
  • Clinical Trials
  • Resources
    • Publications
    • Physician Product Manuals
    • Reimbursement References
    • MRI Guidelines
  • Product
    • The RNS System
    • nSight Platform
    • MRI Safety
    • DIXI US Products
  • Clinical Benefits
    • Seizure Reduction
    • Quality of Life
    • Proven Safety
  • Actionable Insights
    • Real World EEG Data
    • Monitor Patients Remotely
    • Assess Treatment Effects
    • Counsel Patients
  • Patient Selection
    • Neocortical
    • Mesial Temporal
  • Education
    • Webinars
    • RNS System Education
    • Fellows Education
    • Programming Resources
  • Clinical Trials
  • Resources
    • Publications
    • Physician Product Manuals
    • Reimbursement References
    • MRI Guidelines
Press enter to begin your search

Mesial Temporal Onset

Treat mesial temporal onset seizures with RNS System

Some Mesial Temporal Onset Seizures are Difficult to Treat

  • Bilateral Mesial Temporal (MTL) cases, where surgical resection is not an option
  • Dominant Unilateral MTL cases, where risk of cognitive deficits may be unacceptable to the patient
  • When lateralization information is discordant and long-term data is needed to guide the surgical plan

How the RNS® System can help


without cognitive deficit1

The RNS System enables patients to preserve cognitive function while also achieving substantial seizure reduction, making treatment possible for those who may not be good surgical candidates.

Read about MTL Patient Outcomes with the RNS System

 


with real world iEEG data2,3

Using the RNS System before resection gives you long-term EEG data to inform seizure lateralization. This may help identify surgical candidates and improve outcomes.

Read about Informing Lateralization with the RNS System

Erick is an RNS System patient with bilateral hippocampi seizures

“My seizures came from both hippocampi, so I wasn’t a surgery candidate. The device gained control over seizures on the left side of my brain.

After reviewing the data my doctors realized that the majority of my seizures were coming from the right side. So, they decided that I could have surgery to remove the right side of my hippocampus.”

Read His Story

Erick

RNS System patient since 2009, whose seizures
originate in both hippocampi.*

MTL Case Studies

  • Bilateral Hippocampal Onset
  • Unilateral Hippocampal Onset

1. Geller, et al., Epilepsia, 2017. 2. King-Stephens et al., Epilepsia, 2015. 3. Hirsch, et al., Epilepsia, 2020.

*Every individual’s seizures are different and results will vary.

More questions? Contact an RNS System Professional.

Send a message

  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

ABOUT US

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure
  • PATIENTS

    Safety
  • PROVIDERS

    Legal
  • INVESTORS

    Privacy Policy
  • ABOUT US

1-866-726-3876 24-hr Support Line

© 2026 NeuroPace, Inc..

Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.
  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • PDMS
  • nSight
  • Take the Quiz